TeleTrader 2025-10-28 Europe in premarket as more earnings pour in
GlobeNewswire 2025-10-28 Novartis announces expiration of Tourmaline Bio tender offer 
TeleTrader 2025-10-28 Novartis posts Q3 sales of $13.9 billion, up by 7%
GlobeNewswire 2025-10-28 Novartis delivers solid sales and core operating income growth with strong pipeline progress in Q3; ...
GlobeNewswire 2025-10-27 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Essential U...
GlobeNewswire 2025-10-27 CMS (867.HK; 8A8.SG) Signed A Distribution Agreement for Ophthalmic Drugs Lucentis® and Beovu®
TeleTrader 2025-10-27 Novartis CEO defends Avidity deal
GlobeNewswire 2025-10-27 Amphista Therapeutics’ successful degradation of a key cancer target, BRD9, via a novel mechanism wi...
GlobeNewswire 2025-10-26 RNA STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF AVIDITY BIOSCIENCES, INC. IS ...
TeleTrader 2025-10-26 Novartis to buy Avidity Biosciences for $12B
GlobeNewswire 2025-10-26 Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its ...
GlobeNewswire 2025-10-25 Novartis showcases significant immunology advancements in ACR congress with new data in complex auto...
GlobeNewswire 2025-10-24 Evolving Treatment Landscape for Chronic Spontaneous Urticaria Highlights Significant Unmet Needs an...
GlobeNewswire 2025-10-24 Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2025 on the Potential of MRT-61...
GlobeNewswire 2025-10-23 Cingulate’s Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting
GlobeNewswire 2025-10-23 Amphista Therapeutics announces three key strategic leadership appointments to drive transition of i...
GlobeNewswire 2025-10-23 NRG Therapeutics Announces Senior Appointments as it Advances NRG5051 Towards First-in-Human Clinica...
GlobeNewswire 2025-10-22 Novartis Cosentyx® meets primary and all secondary endpoints in Phase III trial in patients with pol...
GlobeNewswire 2025-10-22 Novartis announces expiration of Hart-Scott-Rodino waiting period of Tourmaline Bio tender offer
GlobeNewswire 2025-10-20 Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Cli...
GlobeNewswire 2025-10-19 PSMAddition data show Novartis Pluvicto™ delays progression to end-stage prostate cancer
GlobeNewswire 2025-10-17 Valitor Appoints Biotech and Ophthalmic Industry Veteran Gregory D. Kunst as Chief Executive Officer
GlobeNewswire 2025-10-17 Novartis Kisqali® 5-year NATALEE data demonstrate 28% reduction in risk of recurrence in the broades...
GlobeNewswire 2025-10-17 Novartis Scemblix® receives positive CHMP opinion for the treatment of adults with newly diagnosed C...
GlobeNewswire 2025-10-16 Sjögren’s Disease Remains an Underdiagnosed and Underguided Condition, Creating an Opening for Manuf...